INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 4 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
| Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
| Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
| SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
| Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
| JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
| TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
| GAM Holding AG | 83,940 | $745,000 | 0.03% |
| Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |